Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Bausch & Lomb reports progress with breakthrough treatment for serious eye diseases

May 11, 2000

Akorn obtains rights to AMD technology

May 9, 2000

Known antianginal agent claimed for use in retinal diseases by French researchers

May 9, 2000

Preliminary phase II results for Optin in AMD

May 9, 2000

Actin polymerization inducer jasplakinolide improves outflow facility in primate model

May 5, 2000

News from ARVO: ISV-205 reduces corticosteroid-induced IOP elevations

May 5, 2000

Final results of phase I/IIa trial evaluating CAT-152 in trabeculectomy patients announced at ARVO

May 5, 2000

News from ARVO: antiglaucoma activity of p160ROCK kinase inhibitor

May 3, 2000

Chiron team identifies promising treatment for retinitis pigmentosa

May 3, 2000

New formulations of carteolol may reduce dosing frequency

May 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...